These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24259252)

  • 1. Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.
    Cassol E; Misra V; Morgello S; Gabuzda D
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1087-97. PubMed ID: 24259252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
    Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.
    Lyons JL; Uno H; Ancuta P; Kamat A; Moore DJ; Singer EJ; Morgello S; Gabuzda D
    J Acquir Immune Defic Syndr; 2011 Aug; 57(5):371-9. PubMed ID: 21646912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda.
    Abassi M; Morawski BM; Nakigozi G; Nakasujja N; Kong X; Meya DB; Robertson K; Gray R; Wawer MJ; Sacktor N; Boulware DR
    J Neurovirol; 2017 Jun; 23(3):369-375. PubMed ID: 27995575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-associated neurocognitive disorder.
    Smail RC; Brew BJ
    Handb Clin Neurol; 2018; 152():75-97. PubMed ID: 29604986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
    Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
    AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma CXCL10 correlates with HAND in HIV-infected women.
    Burlacu R; Umlauf A; Marcotte TD; Soontornniyomkij B; Diaconu CC; Bulacu-Talnariu A; Temereanca A; Ruta SM; Letendre S; Ene L; Achim CL
    J Neurovirol; 2020 Feb; 26(1):23-31. PubMed ID: 31414350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study.
    Vassallo M; Dunais B; Durant J; Carsenti-Dellamonica H; Harvey-Langton A; Cottalorda J; Ticchioni M; Laffon M; Lebrun-Frenay C; Dellamonica P; Pradier C
    J Neurovirol; 2013 Aug; 19(4):376-82. PubMed ID: 23846287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review.
    Williams ME; Stein DJ; Joska JA; Naudé PJW
    J Neuroimmunol; 2021 Sep; 358():577649. PubMed ID: 34280844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIV.
    Swanta N; Aryal S; Nejtek V; Shenoy S; Ghorpade A; Borgmann K
    J Neurovirol; 2020 Jun; 26(3):358-370. PubMed ID: 32193795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.
    Coban H; Robertson K; Smurzynski M; Krishnan S; Wu K; Bosch RJ; Collier AC; Ellis RJ
    AIDS; 2017 Jul; 31(11):1565-1571. PubMed ID: 28471765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current understanding of HIV-associated neurocognitive disorders pathogenesis.
    Gannon P; Khan MZ; Kolson DL
    Curr Opin Neurol; 2011 Jun; 24(3):275-83. PubMed ID: 21467932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
    Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
    Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?
    Bandera A; Taramasso L; Bozzi G; Muscatello A; Robinson JA; Burdo TH; Gori A
    Front Aging Neurosci; 2019; 11():187. PubMed ID: 31427955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-associated neurological disorders: a guide to pharmacotherapy.
    Tan IL; McArthur JC
    CNS Drugs; 2012 Feb; 26(2):123-34. PubMed ID: 22201342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.
    Gill AJ; Kolson DL
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):325-35. PubMed ID: 24929842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.
    Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A
    Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.